Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1921 AL 1935

Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation

Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buée L, Debyser Z, Baekelandt V, Gerard M.

J Biol Chem. 2011 Jul 29;286(30):26687-701. doi: 10.1074/jbc.M110.182303. Epub 2011 Jun 7.

Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?

Verhoeven WM, Egger JI, Kremer BP, de Pont BJ, Marcelis CL.

Neuropsychiatr Dis Treat. 2011;7:293-6. doi: 10.2147/NDT.S20153. Epub 2011 May 15.

Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism

Fujioka S, Wszolek ZK.

J Mol Neurosci. 2011 Nov;45(3):359-65. doi: 10.1007/s12031-011-9568-5. Epub 2011 Jun 8.

Newly developed back pain after subthalamic nucleus stimulation in Parkinson's disease

Umemura A, Oka Y, Okura A, Okita K, Yamada K.

Acta Neurochir (Wien). 2011 Aug;153(8):1591-2. doi: 10.1007/s00701-011-1066-6. Epub 2011 Jun 9.

Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred)

Gwinn K, Devine MJ, Jin LW, Johnson J, Bird T, Muenter M, Waters C, Adler CH, Caselli R, Houlden H, Lopez G, Singleton A, Hardy J, Singleton A.

Mov Disord. 2011 Sep;26(11):2134-6. doi: 10.1002/mds.23776. Epub 2011 Jun 8.

Paraquat- and rotenone-induced models of Parkinson's disease

Nisticò R, Mehdawy B, Piccirilli S, Mercuri N.

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):313-22. doi: 10.1177/039463201102400205.

Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities

Lee HJ, Bae EJ, Jang A, Ho DH, Cho ED, Suk JE, Yun YM, Lee SJ.

J Neurosci Methods. 2011 Aug 15;199(2):249-57. doi: 10.1016/j.jneumeth.2011.05.020. Epub 2011 May 31.

Neuropsychological correlates of olfactory dysfunction in Parkinson's disease

Morley JF, Duda JE.

J Neurol Sci. 2011 Nov 15;310(1-2):228-30. doi: 10.1016/j.jns.2011.05.030. Epub 2011 Jun 11.

Anhedonia in Parkinson's disease: a systematic review of the literature

Assogna F, Cravello L, Caltagirone C, Spalletta G.

Mov Disord. 2011 Aug 15;26(10):1825-34. doi: 10.1002/mds.23815. Epub 2011 Jun 9.

Pathological gambling in Parkinson's disease--a review of the literature

Djamshidian A, Cardoso F, Grosset D, Bowden-Jones H, Lees AJ.

Mov Disord. 2011 Sep;26(11):1976-84. doi: 10.1002/mds.23821. Epub 2011 Jun 9.

Increased levels of endothelial progenitor cells in Parkinson's disease

Cavanna F, Barichella M, Cassani E, Pezzoli G.

Parkinsonism Relat Disord. 2011 Sep;17(8):651-2. doi: 10.1016/j.parkreldis.2011.05.015. Epub 2011 Jun 12.

The effects of vitamin D on brain development and adult brain function

Kesby JP, Eyles DW, Burne TH, McGrath JJ.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):121-7. doi: 10.1016/j.mce.2011.05.014. Epub 2011 Jun 1.

[Heart failure in a patient with Wolff-Parkinson-White syndrome]

Martí-Almor J, Bazan V, Morales M, Guerra JC.

Rev Esp Cardiol. 2011 Dec;64(12):1217-8. doi: 10.1016/j.recesp.2011.01.013. Epub 2011 Jun 12.

Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea

Bédard C, Wallman MJ, Pourcher E, Gould PV, Parent A, Parent M.

Parkinsonism Relat Disord. 2011 Sep;17(8):593-8. doi: 10.1016/j.parkreldis.2011.05.012. Epub 2011 Jun 12.

Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients

Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L.

Brain. 2011 Jul;134(Pt 7):2074-84. doi: 10.1093/brain/awr121. Epub 2011 Jun 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias